UMCG research’s Post

📢 The FORESIGHT PPP PROGRAM opens for applications! 🎯 FORESIGHT aims to transform Drug Development with Molecular Imaging for Faster, More Effective, and Personalized Treatments. in Oncology, Autoimmune diseases, Cardiovascular diseases And Neurodegenerative diseases. 🕵 Researchers guided by the program coordinators Elisabeth (Liesbeth) de Vries of the UMCG, Guus A.M.S. van Dongen (Amsterdam UMC), John Haanen (The Netherlands Cancer Institute / Antoni van Leeuwenhoek), and Peter H.N. De With (Eindhoven University of Technology) are bringing together unique knowledge of tracer development, bioengineering, imaging and data analysis/AI to perform (pre)clinical molecular imaging studies. 💰 The Top Sector Life Sciences & Health (Health~Holland, Ministry of Economic Affairs) has made available €9 million subsidy for public-private partnerships within the Foresight PPP program between 2025 and 2032. Two rounds of funding calls are open in 2025, based on a two-stage application. 📝 The first round is now open for pre-proposals until 1 June 2025. Do not miss this opportunity to make contact and apply! Through innovative projects, FORESIGHT will demonstrate the power of molecular imaging, in drug development or choice, driving long-term growth in precision medicine. 📑 Informative links: -         Foresight press release: https://lnkd.in/dYhaWeS9 -         Foresight webpage: https://lnkd.in/dttrXjM3 -         Foresight contact: foresight@umcg.nl Dedicated impact and tech transfer officers within the coordinating team are available for guidance in preparation of the applications. UMCG research UMCG Innovation Center IXA - Innovation Exchange Amsterdam Lisa Büller Anneli Kemper Martin Smit Klaas Jan Wientjes Elena Merlo Sindi Hoxha Wiro Niessen #molecularimaging #immunotherapy #FORESIGHT #PPPprogram